Furthermore, the data indicated that PP2A inactivation caused the induction of let-7b, which is generally down-regulated in cancer (including melanoma and prostate cancer) [81,197], even if it is not clear whether let-7b transcription or let-7b processing is modulated by EGCG-induced PP2A activation. The gene discussed is PTPA; the disease is cancer.